Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ( V 5, V 3, and 3 1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection
about
KSHV attachment and entry are dependent on αVβ3 integrin localized to specific cell surface microdomains and do not correlate with the presence of heparan sulfateHerpesviruses and intermediate filaments: close encounters with the third typeMolecular basis of substrate-induced permeation by an amino acid antiporterKSHV Entry and Trafficking in Target Cells-Hijacking of Cell Signal Pathways, Actin and Membrane DynamicsThe ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirusKaposi's sarcoma-associated herpesvirus induces Nrf2 during de novo infection of endothelial cells to create a microenvironment conducive to infectionUpregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stressGenomic analysis of xCT-mediated regulatory network: Identification of novel targets against AIDS-associated lymphoma.Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphomap130Cas scaffolds the signalosome to direct adaptor-effector cross talk during Kaposi's sarcoma-associated herpesvirus trafficking in human microvascular dermal endothelial cellsMolecular mechanism of alpha2beta1 integrin interaction with human echovirus 1.Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stabilityNFAT and CREB regulate Kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2)Herpes simplex virus glycoproteins H/L bind to cells independently of {alpha}V{beta}3 integrin and inhibit virus entry, and their constitutive expression restricts infectionInteraction of c-Cbl with myosin IIA regulates Bleb associated macropinocytosis of Kaposi's sarcoma-associated herpesvirus.c-Cbl-mediated selective virus-receptor translocations into lipid rafts regulate productive Kaposi's sarcoma-associated herpesvirus infection in endothelial cells.Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypesThe glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry.The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.Detergent-induced stabilization and improved 3D map of the human heteromeric amino acid transporter 4F2hc-LAT2.Rhesus monkey rhadinovirus uses eph family receptors for entry into B cells and endothelial cells but not fibroblasts.CIB1 synergizes with EphrinA2 to regulate Kaposi's sarcoma-associated herpesvirus macropinocytic entry in human microvascular dermal endothelial cells.xCT, not just an amino-acid transporter: a multi-functional regulator of microbial infection and associated diseasesInteraction of human tumor viruses with host cell surface receptors and cell entryThe lipid raft-associated protein CD98 is required for vaccinia virus endocytosis.Integrin β1 mediates vaccinia virus entry through activation of PI3K/Akt signaling.ESCRT-I Protein Tsg101 Plays a Role in the Post-macropinocytic Trafficking and Infection of Endothelial Cells by Kaposi's Sarcoma-Associated Herpesvirus.Professional antigen presenting cells in human herpesvirus 8 infection.Exploitation of Cellular Cytoskeletons and Signaling Pathways for Cell Entry by Kaposi's Sarcoma-Associated Herpesvirus and the Closely Related Rhesus Rhadinovirus.Emmprin and KSHV: new partners in viral cancer pathogenesis.Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells.KSHV cell attachment sites revealed by ultra sensitive tyramide signal amplification (TSA) localize to membrane microdomains that are up-regulated on mitotic cellsTegument Proteins of Kaposi's Sarcoma-Associated Herpesvirus and Related Gamma-Herpesviruses.Interaction of KSHV with host cell surface receptors and cell entry.Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells.Beyond RGD: virus interactions with integrins.ESCRT-0 Component Hrs Promotes Macropinocytosis of Kaposi's Sarcoma-Associated Herpesvirus in Human Dermal Microvascular Endothelial Cells.Cellular recognition and macropinocytosis-like internalization of nanoparticles targeted to integrin α2β1.Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.Reactive oxygen species are induced by Kaposi's sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry.
P2860
Q24301376-E3310315-7D5F-4483-AE7B-A97B30805768Q26863328-18881703-915F-4BB6-8465-4BB0985E4193Q27667150-08B9AF6A-96CD-4447-A1AD-F5F3F74DDC0AQ28072153-E343B1C3-2AA5-4545-AEEF-A42F4FDC108FQ28267511-CEFAA3A9-F874-4114-A93F-4997998169DCQ28396451-311FDCF1-07FA-4964-8176-EDA49622B870Q28472699-139FB8BE-37EC-4CB8-AF37-83DD27A9EE6AQ30379938-E41C21C6-E55F-4F9A-A78C-8989B20AD383Q30409463-8AD6191F-9620-47FD-8F4A-FA8459E3683DQ30603548-FC3967BE-576E-498B-B01A-9CD38FA1E44CQ33598453-34D7D358-FB1E-46A9-951C-563F699D6955Q33622464-9DEB1223-B4A5-4E84-B418-D81C3EEBA7B4Q33718186-567310C3-0A4F-40C0-AC9B-03C3DD552847Q33769324-A184FE6D-A961-4F87-A52E-384F9909BC67Q33784584-22F21D2C-83BD-4D37-B86C-C5265DD7B83AQ34027122-92A78221-D33F-47E5-BE3D-B9D589816DA0Q34102739-76863979-35ED-4456-B51B-CE86C8924669Q34120904-70D27E41-F7E1-4268-B1EE-FEF7B8F1FB15Q34279067-5098E25A-AA4A-4F96-AB4C-52AE0C7531D0Q34317859-996E5282-B057-4F01-9D6B-99D5810E8E84Q34733573-C1625954-0792-4818-9D54-9137C97F8528Q35097117-79FD3315-82F2-48B4-95D9-75F3A418F377Q35099427-709A6250-B2F2-4065-B423-D587D49B7FADQ35676027-DB578F3E-91FC-471D-B316-E7D83A71B60EQ35943686-A8BDF116-91A5-4950-ACF2-18DBC6358CAAQ36086790-D4106ECC-C426-4EAE-B5DB-D46607F33D27Q36169558-54CA5DBD-C331-4A47-8086-A8C043BED49CQ36546999-C8DC0A56-5ADC-49D4-9153-20680ED58C4AQ36607885-30845727-8F65-4751-9BEE-B1BA66D71143Q37057685-F6874E11-6B39-4454-B712-9F533EB2B72BQ37634746-7939AC28-39E9-4B01-8879-12010C6733B1Q37638617-13BBA075-BFBA-4064-991A-3C70221520F2Q37995595-6C3DF5B3-0D2D-4E26-99A9-491C8B0154C1Q38262354-A725BFCD-51DA-4A9A-B2FD-13721B01C447Q38348410-DF5B2B9C-98FE-44B2-AC66-63CD88CAD1FDQ38576959-12A6D83D-EC94-4B9F-AB60-3BF241312D46Q38798971-82E1A65F-9D68-45F1-8842-60D1EDB79B99Q38828246-395984A1-BF4D-4E01-AAC2-E28AF8E2FDBBQ38834450-B627D4D3-DA44-4903-9B9F-B76CBB87C753Q39240333-065FC5BE-5787-4773-861A-B73A4DAC30A8
P2860
Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ( V 5, V 3, and 3 1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Kaposi's Sarcoma-Associated He ...... e Postentry Stage of Infection
@ast
Kaposi's Sarcoma-Associated He ...... e Postentry Stage of Infection
@en
Kaposi's Sarcoma-Associated He ...... e Postentry Stage of Infection
@nl
type
label
Kaposi's Sarcoma-Associated He ...... e Postentry Stage of Infection
@ast
Kaposi's Sarcoma-Associated He ...... e Postentry Stage of Infection
@en
Kaposi's Sarcoma-Associated He ...... e Postentry Stage of Infection
@nl
prefLabel
Kaposi's Sarcoma-Associated He ...... e Postentry Stage of Infection
@ast
Kaposi's Sarcoma-Associated He ...... e Postentry Stage of Infection
@en
Kaposi's Sarcoma-Associated He ...... e Postentry Stage of Infection
@nl
P2093
P2860
P3181
P356
P1433
P1476
Kaposi's Sarcoma-Associated He ...... e Postentry Stage of Infection
@en
P2093
Bala Chandran
Fu-Zhang Wang
Hari Raghu
Laszlo Varga
Mohanan Valiya Veettil
Neelam Sharma-Walia
Sathish Sadagopan
P2860
P304
P3181
P356
10.1128/JVI.01146-08
P577
2008-12-01T00:00:00Z